STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
27.94
+0.16 (0.58%)
At close: Sep 5, 2025, 4:00 PM
28.02
+0.08 (0.29%)
After-hours: Sep 5, 2025, 5:22 PM EDT
STAAR Surgical Company Revenue
STAAR Surgical Company had revenue of $44.32M in the quarter ending June 27, 2025, a decrease of -55.23%. This brings the company's revenue in the last twelve months to $224.45M, down -32.59% year-over-year. In the year 2024, STAAR Surgical Company had annual revenue of $313.90M, down -2.64%.
Revenue (ttm)
$224.45M
Revenue Growth
-32.59%
P/S Ratio
6.14
Revenue / Employee
$193,992
Employees
1,157
Market Cap
1.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 27, 2024 | 313.90M | -8.51M | -2.64% |
Dec 29, 2023 | 322.42M | 38.02M | 13.37% |
Dec 30, 2022 | 284.39M | 53.92M | 23.40% |
Dec 31, 2021 | 230.47M | 67.01M | 41.00% |
Jan 1, 2021 | 163.46M | 13.28M | 8.84% |
Jan 3, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
STAA News
- 3 days ago - STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger - Business Wire
- 4 days ago - Broadwood Announces Intent to Vote Against Acquisition of STAAR Surgical by Alcon - Business Wire
- 17 days ago - Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - Business Wire
- 4 weeks ago - STAAR SURGICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of STAAR Surgical Company - STAA - Business Wire
- 4 weeks ago - STAAR Surgical Reports Second Quarter 2025 Results - Business Wire
- 4 weeks ago - Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - GlobeNewsWire
- 4 weeks ago - Top 2 Health Care Stocks You May Want To Dump In Q3 - Benzinga
- 4 weeks ago - Alcon Agrees to Acquire STAAR Surgical - Business Wire